Noninvasive assessment of patients with alcoholic liver disease

Clinical Liver Disease

Volumn 2, Issue 2, 2013, Pages 68-71

  Mueller, Sebastian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBOHYDRATE DEFICIENT TRANSFERRIN; ETHYL GLUCURONIDE; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; HYALURONIC ACID; TRANSFERRIN; BIOLOGICAL MARKER;

ACOUSTIC RADIATION FORCE IMPULSE IMAGING; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOLIC FATTY LIVER; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELASTOGRAPHY; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATOBILIARY PARAMETERS; HUMAN; IMAGING SYSTEM; LIVER STIFFNESS; MAGNETIC RESONANCE ELASTOGRAPHY; MEAN CORPUSCULAR VOLUME; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SHEAR WAVE ELASTOGRAPHY; THROMBOCYTE COUNT; TRANSIENT ELASTOGRAPHY; BLOOD ANALYSIS; COMORBIDITY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIGESTIVE TRACT PARAMETERS; LIVER FIBROSIS; NON INVASIVE PROCEDURE; REVIEW;

EID: 84910656171     PISSN: None     EISSN: 20462484     Source Type: Journal    
DOI: 10.1002/cld.186     Document Type: Article

References (12)

1. Seitz HK, Mueller S. Alcoholic liver disease. In: Dancygier H, ed. Clinical Hepatology: Principles and Practice of Hepatobiliary Diseases. Heidelberg, Germany: Springer; 2009: 1111-1152.
2. European Association for the Study of the Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 2012; 57: 399-420.
3. Naveau S, Gaude G, Asnacios A, Agostini H, Abella A, Barri-Ova N, et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 2009; 49: 97-105.
4. Pares A, Deulofeu R, Gimenez A, Caballeria L, Bruguera M, Caballeria J, et al. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996; 24: 1399-1403.
5. Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, et al. Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010; 36: 1825-1835.
6. Mueller S, Sandrin L. Liver stiffness: a novel parameter for the diagnosis of liver disease. Hepatic Med 2010; 2: 49-67.
7. Castera L, Pinzani M. Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 2010; 59: 861-866.
8. Nguyen-Khac E, Chatelain D, Tramier B, Decrombecque C, Robert B, Joly JP, et al. Assessment of asymptomatic liver fibrosis in alcoholic patients using FibroScan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther 2008; 28: 1188-1198.
9. Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol 2010; 16: 966-972.
10. Trabut JB, Thepot V, Nalpas B, Lavielle B, Cosconea S, Corouge M, et al. Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. Alcohol Clin Exp Res 2012; 36: 1407-1411.
11. Gelsi E, Dainese R, Truchi R, Marine-Barjoan E, Anty R, Autuori M, et al. Effect of detoxification on liver stiffness assessed by FibroScan® in alcoholic patients. Alcohol Clin Exp Res 2011; 35: 566-570.
12. Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 2011; 60: 977-984.